產(chǎn)品名稱 |
NCI-H2135 [H2135] |
商品貨號 |
B165318 |
Organism |
Homo sapiens, human |
Tissue |
lung |
Product Format |
frozen |
Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Disease |
non-small cell lung cancer |
Applications |
The line was established in February 1989. |
Derivation |
The line was established in February 1989. |
Clinical Data |
The tissue donor was a non-smoker. |
Comments |
The line was established in February 1989. The tissue donor was a non-smoker. |
Complete Growth Medium |
HITES medium supplemented with 5% fetal bovine serum
The base medium for this cell line is ATCC-formulated DMEM:F12 Medium Catalog No.30-2006. To make the complete growth medium,add the following components to the base medium- 0.005 mg/ml Insulin
- 0.01 mg/ml Transferrin
- 30nM Sodium selenite (final conc.)
- 10 nM Hydrocortisone (final conc.)
- 10 nM beta-estradiol (final conc.)
- extra 2mM L-glutamine (for final conc. of 4.5 mM)
- 5% fetal bovine serum (final conc.)
|
Subculturing |
Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density) Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 2 to 3 X 10 exp5 viable cells/ml. Maintain cultures at cell concentrations between 2 X 10 exp5 and 5 X 10 exp5 viable cells/ml. Adherent cells may be harvested by scraping. |
Cryopreservation |
Culture medium, 95%; DMSO, 5% |
Culture Conditions |
Temperature: 37.0°C |
STR Profile |
Amelogenin: X CSF1PO: 12 D13S317: 12 D16S539: 11,12 D5S818: 12,13 D7S820: 11,12 THO1: 9.3 TPOX: 8 vWA: 17,18 |
Name of Depositor |
AF Gazdar, JD Minna |
Deposited As |
Homo sapiens |
Year of Origin |
1989 |
References |
NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996.
|